際際滷shows by User: fjorgensen / http://www.slideshare.net/images/logo.gif 際際滷shows by User: fjorgensen / Sun, 18 Oct 2009 20:27:06 GMT 際際滷Share feed for 際際滷shows by User: fjorgensen The Value of Drug Monitoring in Chronic Opioid Therapy Patients /slideshow/the-value-of-drug-monitoring-in-chronic-opioid-therapy-patients-["2270045"]/2270045 aspmn-final-deckharry-leider2-1255915475-phpapp02
The Value of Drug Monitoring in Chronic Opioid Therapy Patients delivered by Dr. Harry Leider, M.D., MBA, and Chief Medical Officer of Ameritox, Inc. This presentation was delivered during the Managing a Patients Pain in Todays Regulated Environment portion of the 2009 ASPMN Annual Conference.]]>
The Value of Drug Monitoring in Chronic Opioid Therapy Patients delivered by Dr. Harry Leider, M.D., MBA, and Chief Medical Officer of Ameritox, Inc. This presentation was delivered during the Managing a Patients Pain in Todays Regulated Environment portion of the 2009 ASPMN Annual Conference.]]> Sun, 18 Oct 2009 20:27:06 GMT /slideshow/the-value-of-drug-monitoring-in-chronic-opioid-therapy-patients-["2270045"]/2270045 fjorgensen@slideshare.net(fjorgensen) The Value of Drug Monitoring in Chronic Opioid Therapy Patients fjorgensen The Value of Drug Monitoring in Chronic Opioid Therapy Patients delivered by Dr. Harry Leider, M.D., MBA, and Chief Medical Officer of Ameritox, Inc. This presentation was delivered during the Managing a Patients Pain in Todays Regulated Environment portion of the 2009 ASPMN Annual Conference. <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/aspmn-final-deckharry-leider2-1255915475-phpapp02-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br> The Value of Drug Monitoring in Chronic Opioid Therapy Patients delivered by Dr. Harry Leider, M.D., MBA, and Chief Medical Officer of Ameritox, Inc. This presentation was delivered during the Managing a Patients Pain in Todays Regulated Environment portion of the 2009 ASPMN Annual Conference.
The Value of Drug Monitoring in Chronic Opioid Therapy Patients from Fred Jorgensen
]]> 9 2 https://cdn.slidesharecdn.com/ss_thumbnails/aspmn-final-deckharry-leider2-1255915475-phpapp02-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 0 The Value of Drug Monitoring in Chronic Opioid Therapy Patients /slideshow/the-value-of-drug-monitoring-in-chronic-opioid-therapy-patients/2269926 aspmnfinaldeckharryleider2-091018195658-phpapp02
The Value of Drug Monitoring in Chronic Opioid Therapy Patients delivered by Dr. Harry Leider, M.D., MBA, and Chief Medical Officer of Ameritox, Inc. This presentation was delivered during the Managing a Patients Pain in Todays Regulated Environment portion of the 2009 ASPMN Annual Conference.]]>
The Value of Drug Monitoring in Chronic Opioid Therapy Patients delivered by Dr. Harry Leider, M.D., MBA, and Chief Medical Officer of Ameritox, Inc. This presentation was delivered during the Managing a Patients Pain in Todays Regulated Environment portion of the 2009 ASPMN Annual Conference.]]> Sun, 18 Oct 2009 19:56:49 GMT /slideshow/the-value-of-drug-monitoring-in-chronic-opioid-therapy-patients/2269926 fjorgensen@slideshare.net(fjorgensen) The Value of Drug Monitoring in Chronic Opioid Therapy Patients fjorgensen The Value of Drug Monitoring in Chronic Opioid Therapy Patients delivered by Dr. Harry Leider, M.D., MBA, and Chief Medical Officer of Ameritox, Inc. This presentation was delivered during the Managing a Patients Pain in Todays Regulated Environment portion of the 2009 ASPMN Annual Conference. <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/aspmnfinaldeckharryleider2-091018195658-phpapp02-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br> The Value of Drug Monitoring in Chronic Opioid Therapy Patients delivered by Dr. Harry Leider, M.D., MBA, and Chief Medical Officer of Ameritox, Inc. This presentation was delivered during the Managing a Patients Pain in Todays Regulated Environment portion of the 2009 ASPMN Annual Conference.
The Value of Drug Monitoring in Chronic Opioid Therapy Patients from Fred Jorgensen
]]> 2011 11 https://cdn.slidesharecdn.com/ss_thumbnails/aspmnfinaldeckharryleider2-091018195658-phpapp02-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 0 https://public.slidesharecdn.com/v2/images/profile-picture.png http://www.ameritox.com https://cdn.slidesharecdn.com/ss_thumbnails/aspmn-final-deckharry-leider2-1255915475-phpapp02-thumbnail.jpg?width=320&height=320&fit=bounds slideshow/the-value-of-drug-monitoring-in-chronic-opioid-therapy-patients-["2270045"]/2270045 The Value of Drug Mon... https://cdn.slidesharecdn.com/ss_thumbnails/aspmnfinaldeckharryleider2-091018195658-phpapp02-thumbnail.jpg?width=320&height=320&fit=bounds slideshow/the-value-of-drug-monitoring-in-chronic-opioid-therapy-patients/2269926 The Value of Drug Mon...